Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Cannabis Intoxication and Propofol-Induced Salivation: Causes and Considerations.

Pathophysiology : the official journal of the International Society for Pathophysiology·2022
Same author

Risk Stratification in Post-ERCP Pancreatitis: How Do Procedures, Patient Characteristics and Clinical Indicators Influence Outcomes?

Pathophysiology : the official journal of the International Society for Pathophysiology·2022
Same author

Clinical Presentation of Hepatocellular Carcinoma in African Americans vs. Caucasians: A Retrospective Analysis.

Pathophysiology : the official journal of the International Society for Pathophysiology·2022
Same author

Comparison of RNA synthesis initiation properties of non-segmented negative strand RNA virus polymerases.

PLoS pathogens·2021
Same author

Strategies for living well with hormone-responsive advanced prostate cancer-a qualitative exploration.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2020
Same author

Co-localization of catalysts within a protein cage leads to efficient photochemical NADH and/or hydrogen production.

Journal of materials chemistry. B·2020

Related Experiment Video

Updated: Jun 27, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Harbingers for Clostridium difficile-associated diarrhea.

Chaitanya Pant1, Phillip N Madonia, Paul Jordan

  • 1Department of Medicine, Louisiana State University Health Science Center, Shreveport, LA, USA. cpant@lsuhsc.edu

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|December 19, 2008
PubMed
Summary

Elevated white blood cell and platelet counts, along with low albumin levels, are reliable indicators for diagnosing Clostridium difficile-associated diarrhea (CDAD) in hospitalized patients. This study confirms these markers even after excluding confounding hematologic disorders.

More Related Videos

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Related Experiment Videos

Last Updated: Jun 27, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Clinical Pathology

Background:

  • Clostridium difficile-associated diarrhea (CDAD) diagnosis relies on clinical symptoms and laboratory tests.
  • Previous studies identified leukocyte count, platelet count, and albumin level as potential surrogate markers for CDAD.
  • Confounding factors, such as hematologic disorders, were not always excluded in prior research.

Purpose of the Study:

  • To evaluate the reliability of leukocyte count, platelet count, and albumin level as surrogate markers for CDAD.
  • To uniquely assess these markers by excluding patients with major hematologic disorders.

Main Methods:

  • Retrospective review of inpatient data.
  • Inclusion criteria: nosocomial diarrhea diagnosis and stool sample testing for C. difficile toxins A and B.
  • Exclusion criteria: patients with major hematologic disorders.

Main Results:

  • Study included 77 C. difficile-positive and 91 C. difficile-negative patients.
  • Patients with CDAD exhibited significantly higher leukocyte and platelet counts compared to controls.
  • Hypoalbuminemia was significantly more prevalent in patients with CDAD.

Conclusions:

  • Leukocytosis, thrombocytosis, and hypoalbuminemia are confirmed as reliable clinical predictors for CDAD.
  • These findings remain valid even after excluding confounding hematologic conditions.
  • The study reinforces the utility of these hematologic markers in diagnosing CDAD.